Vellgus Red Light Team

Bottom line: Repeated low-level red-light therapy (RLRL) is among the most promising non-pharmacological interventions for slowing childhood myopia progression, with randomized trials showing meaningful reductions in axial elongation compared with single-vision spectacles and, in some analyses, outperforming 0.01% atropine and…

Bottom line: Red light therapy (photobiomodulation, or PBM) is not a treatment for iron overload and should never replace therapeutic phlebotomy or chelation. However, a growing body of mechanistic and clinical evidence suggests that PBM may address a secondary consequence…

Primary Sclerosing Cholangitis (PSC) is a rare, progressive cholestatic liver disease for which no effective medical therapy currently exists, and liver transplantation remains the only curative option for advanced disease . Given this therapeutic void, patients and clinicians alike are…

Conclusion Summary: Red light therapy (photobiomodulation) is not an established treatment for Primary Biliary Cholangitis (PBC). Current clinical guidelines for PBC focus exclusively on pharmacological management (UDCA, PPAR agonists, and symptom control) and do not include light therapy . However,…

Bottom line up front: Red light therapy is not a cure for cirrhosis and should never replace antiviral therapy, alcohol cessation, or specialist hepatology care. However, a specific form of infrared/red light technology—delivered via medical-grade bio-information liver treatment devices—has been…

Bottom line: Red light therapy (photobiomodulation, or PBM) is not a generic “anti-inflammatory” gimmick. A growing body of mechanistic and preclinical evidence shows that specific wavelengths—particularly in the red (630–660 nm) and near-infrared range—can directly modulate cytokine expression, shifting the…

Bottom line: Red light therapy (photobiomodulation) is not a cure for ragweed allergy, but peer-reviewed clinical evidence suggests it can significantly reduce nasal symptoms—congestion, sneezing, runny nose, and itching—when applied intranasally. The strongest data supports symptom relief, not allergy elimination.…

Executive Summary: Chigger bites present a unique clinical challenge characterized by intense pruritus and localized inflammatory response. While red light therapy (RLT) is not a primary treatment for the underlying parasitic infestation or potential vector-borne disease, peer-reviewed evidence suggests it…

Bottom line: There is no direct clinical evidence proving red light therapy (photobiomodulation) cures or prevents swimmer’s itch (cercarial dermatitis). However, mechanistically, red light therapy targets the exact downstream inflammatory and pruritic pathways that make swimmer’s itch so uncomfortable. It…